Recap: Royalty Pharma Q1 Earnings


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


 

Royalty Pharma (NASDAQ:RPRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Here's what investors need to know about the announcement.

Earnings

Royalty Pharma missed estimated earnings by 17.81%, reporting an EPS of $0.6 versus an estimate of $0.73.

Revenue was down $11.03 million from the same period last year.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 0.4% increase in the share price the next day.

Here's a look at Royalty Pharma's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.77 0.69 0.69 0.65
EPS Actual 0.80 0.24 0.73 0.18
Revenue Estimate 556.79M 578.20M 483.42M 509.70M
Revenue Actual 576.00M 585.77M 555.00M 573.03M

To track all earnings releases for Royalty Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: EarningsNewsBZI-Recaps